Potassium dependent rescue of a myopathy with core-like structures in mouse

Area of Science:

• Muscle physiology and genetics
• Mitochondrial function
• Ion channel regulation

Background:

• Myopathies, characterized by decreased muscle functionality, can arise from mutations in the ryanodine receptor 1 (RyR1).
• RyR1 mutations are frequently linked to myopathies exhibiting core-like structures in muscle fibers.
• Central Core Disease (CCD) is a specific type of myopathy associated with RyR1 dysfunction.

Purpose of the Study:

• To characterize a novel mouse model of RyR1-associated myopathy.
• To investigate the physiological and pathological mechanisms underlying muscle weakness in this model.
• To identify potential therapeutic strategies targeting potassium homeostasis.

Main Methods:

• Generation and analysis of a heterozygous RyR1 mutant mouse model.
• Assessment of muscle calcium handling, mitochondrial function, and ATP production.
• Investigation of potassium flux and expression of potassium homeostasis regulators.
• Pharmacological and dietary interventions targeting potassium channels and levels.

Main Results:

• The RyR1 mutation led to decreased calcium release sensitivity, reduced myoplasmic calcium, and impaired mitochondrial ATP production.
• Mutant muscle exhibited persistent potassium leaks and altered expression of potassium homeostasis regulators.
• Inhibition of KATP channels or increasing interstitial potassium reversed muscle weakness and fatigue-like symptoms.
• Regulators of potassium homeostasis were identified as potential biomarkers for disease.

Conclusions:

• RyR1 mutations disrupt muscle calcium and energy metabolism, leading to potassium leaks and weakness.
• Targeting potassium homeostasis mechanisms offers a promising therapeutic approach for RyR1-related myopathies.
• Potassium homeostasis regulators may serve as valuable biomarkers for diagnosing and managing central core disease.